PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY.

Published in:

Hematological Oncology, 2023, v. 41, p. 66, doi. 10.1002/hon.3163_31

By:

• Vinti, L.;
• Daw, S.;
• Alvarez, C. Sabado;
• Fagioli, F.;
• Beishuizen, A.;
• Michel, G.;
• Moleti, M. L.;
• Cepelova, M.;
• Thorwarth, A.;
• Rigaud, C.;
• Lopez de Sabando, D. Plaza;
• Landman‐Parker, J.;
• Shen, J.;
• Pillai, P.;
• Marinello, P.;
• Mauz‐Koerholz, C.

Publication type:

Article